• 1
    Forlino A, Cabral WA, Barnes AM, Marini JC. New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol. 2011; 7:54057.
  • 2
    Cole WG. The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta. Clin Orthop Relat Res. 1997; 343:23548.
  • 3
    Cole WG. Advances in osteogenesis imperfecta. Clin Orthop Relat Res. 2002; 401:616.
  • 4
    Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004; 363(9418):137785.
  • 5
    Rauch F, Travers R, Parfitt AM, Glorieux FH. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone. 2000; 26(6):5819.
  • 6
    Traub W, Arad T, Vetter U, Weiner S. Ultrastructural studies of bones from patients with osteogenesis imperfecta. Matrix Biol. 1994; 14:33745.
  • 7
    Alman B, Frasca P. Fracture failure mechanisms in patients with osteogenesis imperfecta. J Orthop Res. 1987; 5(1):13943.
  • 8
    Jameson J, Albert C, Busse B, Smith P, Harris G. 3D micron-scale imaging of the cortical bone canal network in human osteogenesis imperfecta (OI). Proc SPIE 8672, Medical Imaging 2013: Biomedical Applications in Molecular, Structural, and Functional Imaging. 2013 Mar 29.
  • 9
    Fratzl P, Paris O, Klaushofer K, Landis WJ. Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering. J Clin Invest. 1996; 97:396402.
  • 10
    Chipman SD, Sweet HO, McBride DJ Jr, et al. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA. 1993; 90(5):17015.
  • 11
    Grabner B, Landis WJ, Roschger P, et al. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim). Bone. 2001; 29(5):4537.
  • 12
    Kalajzic I, Terzic J, Rumboldt Z, et al. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology. 2002; 143(5):1594601.
  • 13
    McBride DJ Jr, Shapiro JR, Dunn MG. Bone geometry and strength measurements in aging mice with the oim mutation. Calcif Tissue Int. 1998; 62(2):1726.
  • 14
    Miller E, Delos D, Baldini T, Wright TM, Pleshko Camacho N. Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone. Calcif Tissue Int. 2007; 81:20614.
  • 15
    Phillips CL, Bradley DA, Schlotzhauer CL, et al. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density. Bone. 2000; 27(2):21926.
  • 16
    Saban J, Zussman MA, Havey R, Patwardhan AG, Schneider GB, King D. Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta. Bone. 1996; 19(6):5759.
  • 17
    Sims TJ, Miles CA, Bailey AJ, Camacho NP. Properties of collagen in OIM mouse tissues. Connect Tissue Res. 2003; 44:2025.
  • 18
    Vanleene M, Shefelbine SJ. Therapeutic impact of low amplitude high frequency whole body vibrations on the osteogenesis imperfecta mouse bone. Bone. 2013; 53:50714.
  • 19
    Guillot PV, Abass O, Bassett JH, et al. Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood. 2008; 111:171725.
  • 20
    Vanleene M, Saldanha Z, Cloyd KL, et al. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Blood. 2011; 117(3):105360.
  • 21
    Rao SH, Evans KD, Oberbauer AM, Martin RB. Bisphosphonate treatment in the oim mouse model alters bone modeling during growth. J Biomech. 2008; 41(16):33716.
  • 22
    Bargman R, Huang A, Boskey AL, Raggio C, Pleshko N. RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta. Connect Tissue Res. 2010; 51(2):12331.
  • 23
    Nicholls AC, Osse G, Schloon HG, et al. The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta. J Med Genet. 1984; 21(4):25762.
  • 24
    Carriero A, Doube M, Levchuck A, Schneider P, Muller R, Shefelbine SJ. Cortical tissue porosity of brittle osteogenesis imperfecta bone. Presented at: 57th Annual Meeting of the Orthopaedic Research Society; January 13–16, 2011; Long Beach, CA.
  • 25
    Vanleene M, Porter A, Guillot PV, Boyde A, Oyen M, Shefelbine S. Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice. Bone. 2012; 50:131723.
  • 26
    Camacho NP, Hou L, Toledano TR, et al. The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res. 1999; 14:26472.
  • 27
    ASTM_E1820-09. Standard test method for measurement of fracture toughness. Annual book of Americal Society for Testing and Material Standards. West Conshohocken, PA: ASTM International; 2006.
  • 28
    ASTM_D790-10. Standard test method for flexural properties of reinforced plastics and electrical insulation materials. Annual book of Americal Society for Testing and Material Standards. West Conshohocken, PA: ASTM International; 2010.
  • 29
    Ritchie RO, Koester KJ, Ionova S, Yao W, Lane NE, Ager JW 3rd. Measurement of the toughness of bone: a tutorial with special reference to small animal studies. Bone. 2008; 43:798812.
  • 30
    Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9(7):6715.
  • 31
    Paluszny A, Zimmerman RW. Numerical simulation of multiple 3D fracture propagation using arbitrary meshes. Comput Methods Appl Mech Eng. 2011; 200:95366.
  • 32
    Taylor D, Prendergast PJ. A model for fatigue crack propagation and remodelling in compact bone. Proc Inst Mech Eng H. 1997; 211(5):36975.
  • 33
    Taylor D, Lee TC. Microdamage and mechanical behaviour: predicting failure and remodelling in compact bone. J Anat. 2003; 203(2):20311.
  • 34
    Taylor D, Tilmans A. Stress intensity variations in bone microcracks during the repair process. J Theor Biol. 2004; 229:16977.
  • 35
    Wright TM, Hayes WC. The fracture mechanics of fatigue crack propagation in compact bone. J Biomed Mater Res. 1976; 10:63748.
  • 36
    Barth HD, Launey ME, MacDowell AA, Ager JW, Ritchie RO. On the effect of X-ray irradiation on the deformation and fracture behavior of human cortical bone. Bone. 2010; 46:147585.
  • 37
    Gupta HS, Seto J, Wagermaier W, Zaslansky P, Boesecke P, Fratzl P. Cooperative deformation of mineral and collagen in bone at the nanoscale. Proc Natl Acad Sci USA. 2006; 103:177416.
  • 38
    Sell DR, Monnier VM. Isolation, purification and partial characterization of novel fluorophores from aging human insoluble collagen-rich tissue. Connect Tissue Res. 1989; 19(1):7792.
  • 39
    Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961; 93:4407.
  • 40
    Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010; 21:195214.
  • 41
    Miles CA, Sims TJ, Camacho NP, Bailey AJ. The role of the alpha2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues. J Mol Biol. 2002; 321:797805.
  • 42
    Bell KL, Loveridge N, Power J, Garrahan N, Meggitt BF, Reeve J. Regional differences in cortical porosity in the fractured femoral neck. Bone. 1999; 24(1):5764.
  • 43
    Yeni YN, Brown CU, Wang Z, Norman TL. The influence of bone morphology on fracture toughness of the human femur and tibia. Bone. 1997; 21(5):4539.
  • 44
    Launey ME, Buehler MJ, Ritchie RO. On the mechanistic origins of toughness in bone. Ann Rev Mater Res. 2010; 40:2553.
  • 45
    Koester KJ, Ager JW, Ritchie RO. The true toughness of human cortical bone measured with realistically short cracks. Nat Mater. 2008; 7:6727.
  • 46
    Zimmermann EA, Schaible E, Bale H, et al. Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales. Proc Natl Acad Sci USA. 2011; 108:1441621.
  • 47
    Peterlik H, Roschger P, Klaushofer K, Fratzl P. From brittle to ductile fracture of bone. Nat Mater. 2006; 5(1):525.
  • 48
    Jepsen KJ, Goldstein SA, Kuhn JL, Schaffler MB, Bonadio J. Type-I collagen mutation compromises the post-yield behavior of Mov13 long bone. J Orthop Res. 1996; 14(3):4939.
  • 49
    Mehta SS, Antich PP, Landis WJ. Bone material elasticity in a murine model of osteogenesis imperfecta. Connect Tissue Res. 1999; 40(3):18998.
  • 50
    Jepsen KJ, Schaffler MB, Kuhn JL, Goulet RW, Bonadio J, Goldstein SA. Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue. J Biomech. 1997; 30(11–12):11417.
  • 51
    Camacho NP, Landis WJ, Boskey AL. Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy. Connect Tissue Res. 1996; 35(1–4):25965.
  • 52
    Wasserman N, Yerramshetty J, Akkus O. Microcracks colocalize within highly mineralized regions of cortical bone tissue. Eur J Morphol. 2005; 42:4351.
  • 53
    Li H, Jiang X, Delaney J, et al. Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol. 2010; 176:240513.
  • 54
    Currey JD. The mechanical consequences of variation in the mineral content of bone. J Biomech. 1969; 2(1):111.
  • 55
    Currey JD. The relationship between the stiffness and the mineral content of bone. J Biomech. 1969; 2(4):47780.
  • 56
    Chang SW, Shefelbine SJ, Buehler MJ. Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease. Biophys J. 2012; 102:6408.
  • 57
    Cole WG. The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta. Clin Orthop Relat Res. 1997(343):23548.
  • 58
    Cole WG. Advances in osteogenesis imperfecta. Clin Orthop Relat Res. 2002; (401):616.
  • 59
    Knott L, Whitehead CC, Fleming RH, Bailey AJ. Biochemical changes in the collagenous matrix of osteoporotic avian bone. Biochem J. 1995; 310:104551.
  • 60
    Phillips CL, Pfeiffer BJ, Luger AM, Franklin CL. Novel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim). Kidney Int. 2002; 62:38391.
  • 61
    Vashishth D. The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep. 2007; 5(2):626.
  • 62
    Wang X, Shen X, Li X, Agrawal CM. Age-related changes in the collagen network and toughness of bone. Bone. 2002; 31(1):17.
  • 63
    Coleman RM, Aguilera L, Quinones L, Lukashova L, Poirier C, Boskey A. Comparison of bone tissue properties in mouse models with collagenous and non-collagenous genetic mutations using FTIRI. Bone. 2012; 51(5):9208.